Page last updated: 2024-12-08

1-dehydroprogesterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-dehydroprogesterone (1-DHP) is a synthetic steroid hormone that is a **potent agonist of the progesterone receptor**.

Here's why it's important for research:

* **Progesterone Receptor Research:** 1-DHP acts as a powerful tool to study the progesterone receptor and its signaling pathways. It's used to investigate the molecular mechanisms of progesterone action in various tissues and biological processes.
* **Drug Development:** 1-DHP is a promising lead compound for developing new drugs that target the progesterone receptor. Potential applications include:
* **Contraception:** Like progesterone itself, it can suppress ovulation.
* **Hormone Replacement Therapy (HRT):** It can potentially alleviate menopausal symptoms.
* **Treatment of Uterine Fibroids:** It might be effective in reducing the size of fibroids.
* **Cancer Treatment:** 1-DHP has shown potential in treating certain types of cancer, particularly those driven by progesterone receptor activity.
* **Animal Models:** 1-DHP is used to create animal models of various physiological and pathological conditions related to progesterone signaling, allowing researchers to study the effects of progesterone deficiency or excess in various systems.

**Important Note:** 1-DHP is a synthetic compound and not naturally occurring. It's typically used in laboratory settings and research, not as a therapeutic agent in the general population. Further research is needed to fully understand its potential benefits and risks.

1-dehydroprogesterone: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Delta(1)-progesterone : A 3-oxo Delta(4)-steroid that is progesterone which has been oxidised to introduce a double bond between positions 1 and 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID247929
CHEMBL ID479717
CHEBI ID34073
SCHEMBL ID524063
MeSH IDM0116821

Synonyms (29)

Synonym
1,4-pregnadiene-3,20-dione
257v0w056g ,
unii-257v0w056g
CHEMBL479717
.delta.1-progesterone
pregna-1,20-dione
1162-54-5
mls002693437 ,
nsc63538
1,2-dehydroprogesterone
1-dehydroprogesterone
nsc-63538
nsc 63538
pregna-1,4-diene-3,20-dione
delta1-progesterone
1,2-didehydroprogesterone
3,20-dioxo-pregna-1,4-diene
CHEBI:34073 ,
3,20-dioxo-1,4-pregnadiene
delta(1)-progesterone
LMST02030147
(8s,9s,10r,13s,14s,17s)-17-acetyl-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
progesterone impurity j [ep impurity]
SCHEMBL524063
pregna-1,4-diene-3,20-dione #
(8s,9s,10r,13s,14s,17s)-17-acetyl-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-3-one
DTXSID50921958
1,4-pregnadien-3,20-dione
Q27115793
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
20-oxo steroidAn oxo steroid carrying an oxo group at position 20.
3-oxo-Delta(1),Delta(4)-steroidA 3-oxo-Delta(1) steroid containing an additional double bond between positions 4 and 5.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1150123Relative binding affinity to rabbit progesterone receptor1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
AID1150122Relative binding affinity to sheep progesterone receptor1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
AID1150121Relative binding affinity to human progesterone receptor1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
AID1150124Relative binding affinity to guinea pig progesterone receptor1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]